206 related articles for article (PubMed ID: 28174010)
1. A case of T-cell lymphoproliferative disorder associated with hypereosinophilia with excellent response to mycophenolate mofetil.
Hanbali A; Shaheen M; Alfraih F; Al-Otaibi W; El Fakih R; Owaidah T; Ahmed S
Hematol Oncol Stem Cell Ther; 2018 Dec; 11(4):241-244. PubMed ID: 28174010
[TBL] [Abstract][Full Text] [Related]
2. Lymphoproliferative disorders associated with hypereosinophilia.
Roufosse F; Garaud S; de Leval L
Semin Hematol; 2012 Apr; 49(2):138-48. PubMed ID: 22449624
[TBL] [Abstract][Full Text] [Related]
3. Hypereosinophilic syndrome.
Hsieh FH
Ann Allergy Asthma Immunol; 2014 Jun; 112(6):484-8. PubMed ID: 24726650
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and spectrum of T-cell lymphoproliferative disorders in patients with Hypereosinophilia: A reference laboratory experience.
Shi M; Rech KL; Otteson GE; Horna P; Olteanu H; Pardanani A; Chen D; Jevremovic D
Ann Diagn Pathol; 2020 Feb; 44():151412. PubMed ID: 31778950
[TBL] [Abstract][Full Text] [Related]
5. Hypereosinophilic syndrome in an atopic patient.
Neve S; Beukers S; Kirtschig G
Clin Exp Dermatol; 2009 Dec; 34(8):e643-6. PubMed ID: 19538189
[TBL] [Abstract][Full Text] [Related]
6. Hypereosinophilia with Concurrent Venous Thromboembolism: Clinical Features, Potential Risk Factors, and Short-term Outcomes in a Chinese Cohort.
Liu Y; Meng X; Feng J; Zhou X; Zhu H
Sci Rep; 2020 May; 10(1):8359. PubMed ID: 32433573
[TBL] [Abstract][Full Text] [Related]
7. A Case of Pulmonary Hypertension Associated with Idiopathic Hypereosinophilic Syndrome.
Ibe T; Wada H; Sakakura K; Ugata Y; Ito M; Umemoto T; Momomura SI; Fujita H
Int Heart J; 2018 Jul; 59(4):887-890. PubMed ID: 29794385
[TBL] [Abstract][Full Text] [Related]
8. Marked and persistent eosinophilia in the absence of clinical manifestations.
Chen YY; Khoury P; Ware JM; Holland-Thomas NC; Stoddard JL; Gurprasad S; Waldner AJ; Klion AD
J Allergy Clin Immunol; 2014 Apr; 133(4):1195-202. PubMed ID: 23987798
[TBL] [Abstract][Full Text] [Related]
9. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
Gotlib J
Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
[TBL] [Abstract][Full Text] [Related]
10. Frequency of abnormal T-cells in hypereosinophilic syndrome and hypereosinophilia of undetermined significance- Extended follow-up.
Helbig G; Dziaczkowska-Suszek J; Francuz T; Torba K; Kyrcz-Krzemień S
Eur J Intern Med; 2016 Nov; 35():e14-e15. PubMed ID: 27267517
[No Abstract] [Full Text] [Related]
11. Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: Treatment with interferon alfa and extracorporeal photopheresis.
Lee CH; Mamelak AJ; Vonderheid EC
Int J Dermatol; 2007 Nov; 46(11):1198-204. PubMed ID: 17988344
[TBL] [Abstract][Full Text] [Related]
12. Hypereosinophilic syndrome - lymphocytic variant transforming into peripheral T-cell lymphoma with severe oral manifestations.
d'Elbée JM; Parrens M; Mercié P; Longy Boursier M; Dieval C; de Mascarel A; Duffau P; Dubus P; Fricain JC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):e185-90. PubMed ID: 23669204
[TBL] [Abstract][Full Text] [Related]
13. Incidence of peripheral blood eosinophilia and the threshold eosinophile count for indicating hypereosinophilia-associated diseases.
Kobayashi S; Inokuma S; Setoguchi K; Kono H; Abe K
Allergy; 2002 Oct; 57(10):950-6. PubMed ID: 12269945
[TBL] [Abstract][Full Text] [Related]
14. Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes.
Stella S; Massimino M; Manzella L; Pennisi MS; Tirrò E; Romano C; Vitale SR; Puma A; Tomarchio C; Gregorio SD; Palumbo GA; Vigneri P
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33418988
[TBL] [Abstract][Full Text] [Related]
15. Hypereosinophilic syndrome: progression of peripheral neuropathy despite controlled eosinophil levels.
Cengiz B; Sucak G; Kuruoğlu R; Tan E
Acta Neurol Belg; 1999 Jun; 99(2):133-7. PubMed ID: 10427356
[TBL] [Abstract][Full Text] [Related]
16. IgG4-related disease and lymphocyte-variant hypereosinophilic syndrome: A comparative case series.
Carruthers MN; Park S; Slack GW; Dalal BI; Skinnider BF; Schaeffer DF; Dutz JP; Law JK; Donnellan F; Marquez V; Seidman M; Wong PC; Mattman A; Chen LY
Eur J Haematol; 2017 Apr; 98(4):378-387. PubMed ID: 28005278
[TBL] [Abstract][Full Text] [Related]
17. The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype.
Lefèvre G; Copin MC; Staumont-Sallé D; Avenel-Audran M; Aubert H; Taieb A; Salles G; Maisonneuve H; Ghomari K; Ackerman F; Legrand F; Baruchel A; Launay D; Terriou L; Leclech C; Khouatra C; Morati-Hafsaoui C; Labalette M; Borie R; Cotton F; Gouellec NL; Morschhauser F; Trauet J; Roche-Lestienne C; Capron M; Hatron PY; Prin L; Kahn JE;
Medicine (Baltimore); 2014 Oct; 93(17):255-266. PubMed ID: 25398061
[TBL] [Abstract][Full Text] [Related]
18. Causes of hypereosinophilia in 100 consecutive patients.
Moller D; Tan J; Gauiran DTV; Medvedev N; Hudoba M; Carruthers MN; Dehghan N; van den Berghe J; Bruyère H; Chen LYC
Eur J Haematol; 2020 Sep; 105(3):292-301. PubMed ID: 32364630
[TBL] [Abstract][Full Text] [Related]
19. Does hypereosinophilic syndrome precede common B acute lymphoblastic leukaemia in childhood? A case report.
Ayhan AC; Timur C; Ayhan Y; Cakır B; Erguven M
Acta Haematol; 2012; 127(2):90-2. PubMed ID: 22156491
[TBL] [Abstract][Full Text] [Related]
20. High-risk ALK negative anaplastic large-cell lymphoma presenting with hypereosinophilic syndrome in a 2.5-year-old child.
Tekkeşin F; Pınarlı FG; Kaya Z; Oğuz A; Karadeniz C; Okur A; Akyürek N
Pediatr Hematol Oncol; 2012 Nov; 29(8):686-90. PubMed ID: 23013405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
